Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The underlying goal of this study is to assess PBR-111 positron emission tomography (PET)
imaging as a tool to detect microglial activation in the brain of Alzheimer disease (AD)
research participants and age- and gender-matched healthy volunteers.